NU 641 – ADVANCED CLINICAL PHARMACOLOGY EXAM 3
QUESTIONS AND DETAILED SOLUTIONS JUST RELEASED.PDF
QUESTIONS AND CORRECT ANSWERS (VERIFIED ANSWERS)
PLUS RATIONALES 2026 Q&A | INSTANT DOWNLOAD PDF
Core Domains
Pharmacokinetics and Pharmacodynamics
Cardiovascular Pharmacology
Endocrine Pharmacology
Psychopharmacology and Neurology
Anticonvulsant Therapy and Drug Interactions
Dermatological Pharmacology
Infectious Disease Pharmacotherapy
Women's Health and Contraception
Musculoskeletal and Anti-Inflammatory Therapy
Adverse Drug Reactions and Monitoring
Introduction
This examination assesses the advanced clinical pharmacology
knowledge and prescriptive decision-making skills required of the
advanced practice nurse. It evaluates pharmacokinetic and
pharmacodynamic principles, endocrine and cardiovascular
pharmacology, psychopharmacology, anticonvulsant therapy,
dermatological agents, and women's health pharmacotherapeutics.
Multiple-choice and case-based questions simulate realistic clinical
,encounters. Emphasis is placed on mechanism-based reasoning,
drug-drug interactions, adverse effect monitoring, and evidence-
based pharmacotherapeutics. Successful completion demonstrates
readiness for safe and effective prescriptive practice.
SECTION ONE: QUESTIONS 1–100
1. A patient on an SSRI develops serotonin syndrome after the
addition of linezolid. What is the primary pharmacodynamic
mechanism causing this reaction?
A. MAO-A inhibition by linezolid, increasing synaptic serotonin
levels
B. SSRI-induced CYP2D6 inhibition raising linezolid levels
C. Additive platelet serotonin release from both medications
D. Competitive displacement of serotonin from plasma proteins
🟢 A. MAO-A inhibition by linezolid, increasing synaptic serotonin
levels
🔴 RATIONALE: Linezolid is a reversible, non-selective MAO
inhibitor. When combined with an SSRI, it prevents serotonin
degradation, leading to excess synaptic serotonin and serotonin
syndrome .
2. Which anticonvulsant medications are known to reduce the
effectiveness of hormonal birth control?
A. Levetiracetam and lamotrigine
B. Phenytoin, phenobarbital, and carbamazepine
C. Gabapentin and pregabalin
,D. Valproic acid and topiramate
🟢 B. Phenytoin, phenobarbital, and carbamazepine
🔴 RATIONALE: Enzyme-inducing anticonvulsants increase
metabolism of hormonal contraceptives, reducing their
effectiveness. Patients should be counseled on alternative
contraceptive methods .
3. A patient on methotrexate for rheumatoid arthritis develops
stomatitis and bone marrow suppression. Which rescue therapy
is most appropriate?
A. Folinic acid (leucovorin)
B. Folic acid 1 mg daily
C. Vitamin B12
D. Pyridoxine
🟢 A. Folinic acid (leucovorin)
🔴 RATIONALE: Folinic acid bypasses the blocked dihydrofolate
reductase step and rescues normal cells from methotrexate
toxicity without reversing therapeutic effect .
4. A 70-year-old patient with type 2 diabetes and a history of
multiple falls is on glimepiride. The nurse practitioner should
consider changing this medication for which reason?
A. Glimepiride causes significant weight loss
B. Sulfonylureas increase the risk of hypoglycemia in elderly
patients
C. Glimepiride is nephrotoxic and damages the kidneys
, D. It frequently causes lactic acidosis in older adults
🟢 B. Sulfonylureas increase the risk of hypoglycemia in elderly
patients
🔴 RATIONALE: Sulfonylureas like glimepiride can cause
prolonged and severe hypoglycemia, especially in elderly patients.
This increases fall risk and should prompt consideration of safer
alternatives .
5. A patient with type 2 diabetes on insulin glargine and
metformin has an HbA1c of 9.0%. Empagliflozin is added. What
key counseling point should be included?
A. Risk of significant weight gain
B. Potential for increased appetite
C. Risk of euglycemic diabetic ketoacidosis
D. Need to increase carbohydrate intake
🟢 C. Risk of euglycemic diabetic ketoacidosis
🔴 RATIONALE: SGLT2 inhibitors carry a risk of euglycemic DKA,
where ketoacidosis develops without markedly elevated glucose.
Patients should be counseled on symptoms like nausea and
abdominal pain .
6. A patient is experiencing postprandial hypoglycemia after
starting insulin lispro. What is the most likely cause?
A. The basal insulin dose is too low
B. The rapid-acting insulin dose is excessive relative to meal size
C. The patient is not taking metformin consistently
QUESTIONS AND DETAILED SOLUTIONS JUST RELEASED.PDF
QUESTIONS AND CORRECT ANSWERS (VERIFIED ANSWERS)
PLUS RATIONALES 2026 Q&A | INSTANT DOWNLOAD PDF
Core Domains
Pharmacokinetics and Pharmacodynamics
Cardiovascular Pharmacology
Endocrine Pharmacology
Psychopharmacology and Neurology
Anticonvulsant Therapy and Drug Interactions
Dermatological Pharmacology
Infectious Disease Pharmacotherapy
Women's Health and Contraception
Musculoskeletal and Anti-Inflammatory Therapy
Adverse Drug Reactions and Monitoring
Introduction
This examination assesses the advanced clinical pharmacology
knowledge and prescriptive decision-making skills required of the
advanced practice nurse. It evaluates pharmacokinetic and
pharmacodynamic principles, endocrine and cardiovascular
pharmacology, psychopharmacology, anticonvulsant therapy,
dermatological agents, and women's health pharmacotherapeutics.
Multiple-choice and case-based questions simulate realistic clinical
,encounters. Emphasis is placed on mechanism-based reasoning,
drug-drug interactions, adverse effect monitoring, and evidence-
based pharmacotherapeutics. Successful completion demonstrates
readiness for safe and effective prescriptive practice.
SECTION ONE: QUESTIONS 1–100
1. A patient on an SSRI develops serotonin syndrome after the
addition of linezolid. What is the primary pharmacodynamic
mechanism causing this reaction?
A. MAO-A inhibition by linezolid, increasing synaptic serotonin
levels
B. SSRI-induced CYP2D6 inhibition raising linezolid levels
C. Additive platelet serotonin release from both medications
D. Competitive displacement of serotonin from plasma proteins
🟢 A. MAO-A inhibition by linezolid, increasing synaptic serotonin
levels
🔴 RATIONALE: Linezolid is a reversible, non-selective MAO
inhibitor. When combined with an SSRI, it prevents serotonin
degradation, leading to excess synaptic serotonin and serotonin
syndrome .
2. Which anticonvulsant medications are known to reduce the
effectiveness of hormonal birth control?
A. Levetiracetam and lamotrigine
B. Phenytoin, phenobarbital, and carbamazepine
C. Gabapentin and pregabalin
,D. Valproic acid and topiramate
🟢 B. Phenytoin, phenobarbital, and carbamazepine
🔴 RATIONALE: Enzyme-inducing anticonvulsants increase
metabolism of hormonal contraceptives, reducing their
effectiveness. Patients should be counseled on alternative
contraceptive methods .
3. A patient on methotrexate for rheumatoid arthritis develops
stomatitis and bone marrow suppression. Which rescue therapy
is most appropriate?
A. Folinic acid (leucovorin)
B. Folic acid 1 mg daily
C. Vitamin B12
D. Pyridoxine
🟢 A. Folinic acid (leucovorin)
🔴 RATIONALE: Folinic acid bypasses the blocked dihydrofolate
reductase step and rescues normal cells from methotrexate
toxicity without reversing therapeutic effect .
4. A 70-year-old patient with type 2 diabetes and a history of
multiple falls is on glimepiride. The nurse practitioner should
consider changing this medication for which reason?
A. Glimepiride causes significant weight loss
B. Sulfonylureas increase the risk of hypoglycemia in elderly
patients
C. Glimepiride is nephrotoxic and damages the kidneys
, D. It frequently causes lactic acidosis in older adults
🟢 B. Sulfonylureas increase the risk of hypoglycemia in elderly
patients
🔴 RATIONALE: Sulfonylureas like glimepiride can cause
prolonged and severe hypoglycemia, especially in elderly patients.
This increases fall risk and should prompt consideration of safer
alternatives .
5. A patient with type 2 diabetes on insulin glargine and
metformin has an HbA1c of 9.0%. Empagliflozin is added. What
key counseling point should be included?
A. Risk of significant weight gain
B. Potential for increased appetite
C. Risk of euglycemic diabetic ketoacidosis
D. Need to increase carbohydrate intake
🟢 C. Risk of euglycemic diabetic ketoacidosis
🔴 RATIONALE: SGLT2 inhibitors carry a risk of euglycemic DKA,
where ketoacidosis develops without markedly elevated glucose.
Patients should be counseled on symptoms like nausea and
abdominal pain .
6. A patient is experiencing postprandial hypoglycemia after
starting insulin lispro. What is the most likely cause?
A. The basal insulin dose is too low
B. The rapid-acting insulin dose is excessive relative to meal size
C. The patient is not taking metformin consistently
